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Abstract
Background—Psychological stress is a proposed risk factor for cardiovascular disease (CVD), 
and posttraumatic stress disorder (PTSD), the sentinel stress-related mental disorder, occurs twice 
as frequently in women as men. However, whether PTSD contributes to CVD risk in women is not 
established.
Methods and Results—We examined trauma exposure and PTSD symptoms in relation to 
incident CVD over a 20-year period in 49,978 women in the Nurses’ Health Study II. Proportional 
hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for CVD events 
confirmed by additional information or medical record review [n=548, including myocardial 
infarction (n=277) and stroke (n=271)]. Trauma exposure and PTSD symptoms were assessed 
using the Brief Trauma Questionnaire and a PTSD screen. Compared to no trauma exposure, 
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endorsing 4 or more PTSD symptoms was associated with increased CVD risk after adjusting for 
age, family history, and childhood factors (HR=1.60 [95% CI, 1.20–2.13]). Being trauma-exposed 
and endorsing no PTSD symptoms was associated with elevated CVD risk (HR=1.45 [95% CI, 
1.15–1.83]), although being trauma-exposed and endorsing 1–3 PTSD symptoms was not. After 
adjusting for adult health behaviors and medical risk factors, this pattern of findings was 
maintained. Health behaviors and medical risk factors accounted for 14% of the trauma/no 
symptoms-CVD association and 47% of the trauma/4+ symptoms-CVD association.
Conclusion—Trauma exposure and elevated PTSD symptoms may increase risk of CVD in this 
population of women. These findings suggest screening for CVD risk and reducing health risk 
behaviors in trauma-exposed women may be promising avenues for prevention and intervention.
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Despite progress in risk factor identification and treatment, cardiovascular disease (CVD) 
remains the leading cause of death in women,1 and the prevalence of CVD in middle-aged 
women in particular is on the rise.2 Consequently, there have been calls to expand the scope 
of research beyond established CVD risk factors in order to improve intervention and 
prevention efforts.1 Psychological stress has long been hypothesized to be a risk factor for 
CVD,3 and exposure to extremely stressful or traumatic events, such as childhood adversity4 
and combat,5 has been linked to increased CVD risk. Posttraumatic stress disorder (PTSD) 
occurs in some individuals following trauma exposure and is characterized by re-
experiencing the trauma, avoidance of trauma reminders, emotional numbing, and 
hyperarousal. PTSD, considered the sentinel stress-related mental disorder, is common, with 
lifetime prevalence rates twice as high in women (10%) as in men (5%).6 Evidence for a 
PTSD-CVD relation is suggestive,7 and PTSD has been linked to CVD risk-related 
biomarkers, including elevated inflammatory markers8 and serum lipid concentrations.9 
Nevertheless, a systematic literature review indicated a paucity of large, prospective 
epidemiologic studies of the relations between trauma exposure, PTSD, and CVD, 
particularly among women.10
Despite emerging findings on stress-related mental disorders and CVD, understanding of 
whether PTSD increases risk of CVD is limited in important ways. First, the PTSD-CVD 
relation has been understudied in women. PTSD is more prevalent and associated with 
greater chronicity and impairment in women than men,6, 11 and CVD manifests in unique 
ways in women compared to men.12 Thus, studying the PTSD-CVD relation specifically in 
women is important. To date, of the seven prospective studies of PTSD and incident 
CVD,5, 13–18 only one has been conducted in women.18 This study by Kubzansky et al., 18 
which suggested elevated CVD risk in women with higher PTSD symptoms, relied on self-
reported CVD outcomes, necessitating replication with confirmed outcomes. Second, the 
PTSD-CVD association may be confounded by trauma exposure. It remains unclear whether 
trauma exposure alone or the mental health consequences of trauma, most typically PTSD, 
lead to increased CVD risk. Third, although PTSD has been associated with behavioral risk 
factors for CVD, including cigarette smoking,19 obesity,20 and physical inactivity,21 little 
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research has investigated whether these and other behavioral and medical risk factors 
mediate the PTSD-CVD relation.
We addressed these under-examined issues using data from a sub-sample of the Nurses’ 
Health Study II (NHS II), an ongoing cohort study of younger and middle-aged women 
initiated in 1989. We compared the incidence of CVD events (myocardial infarction [MI] 
and stroke) confirmed by additional information or medical record review over a 20-year 
period in women without trauma exposure and with trauma exposure and different PTSD 
symptom levels. All women were younger than 65 years of age at the end of the study 
period; thus our investigation addressed the association between trauma, PTSD, and early-
onset CVD, an important risk phenotype, particularly in women.12 We also investigated 
health behaviors and medical risk factors as potential mediators of associations between 
trauma, PTSD symptoms, and CVD incidence. We hypothesized that trauma exposure and 
elevated PTSD symptoms would be associated with increased CVD risk compared to no 
trauma exposure, with women with the highest PTSD symptoms showing the most elevated 
risk due to greatest behavioral and biological dysregulation.
Methods
Sample
The NHS II includes 116,430 U.S. female nurses, aged 25–42 years at enrollment in 1989 
and followed biennially. In 2008, when participants were aged 44–62 years, 60,804 women 
who completed the 2001 Violence questionnaire and 2007 biennial questionnaire were 
mailed a supplemental questionnaire assessing trauma exposure and PTSD symptoms.22 To 
maximize retention, supplemental surveys are only sent to those who return biennial 
questionnaires. After repeated mailings, 54,282 women returned the questionnaire (89% 
response rate). This study was approved by the Institutional Review Board of Brigham and 
Women’s Hospital. Return of the questionnaire via U.S. mail constituted implied consent.
Trauma and PTSD Assessment
Trauma exposure was measured with a 16-item modified version of the Brief Trauma 
Questionnaire (BTQ).22 The BTQ is considered a reliable and valid measure of trauma 
exposure that parallels interview measures of trauma exposure.22,23,24 Exposure to 15 
traumatic events (e.g., natural disaster exposure, unwanted sexual contact, physical assault), 
in addition to “a seriously traumatic event not already covered,” was assessed; exposure to 
each event at any point in one’s lifetime was coded as present or absent. Respondents 
identified which event occurred first and which event was their worst or most distressing 
experience. They also reported their ages at the first and worst events. Occurrence of PTSD 
symptoms in participants’ lifetimes was queried with respect to the worst traumatic event 
using the 7-item Short Screening Scale for DSM-IV PTSD.25 This scale assesses seven 
PTSD symptoms (each coded as present or absent). A cutoff score of four has been 
recommended for identifying probable PTSD;25 this cutoff has been found to define positive 
cases of PTSD in other samples with a sensitivity of 85% and specificity of 93%.25 
Reliability of self-reported age-of-onset of trauma and PTSD has been found to be excellent 
in this sample (ICC=.95).
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For each year of the study, participants were categorized into four groups based on the year 
of their first trauma and the year of their worst trauma: 1) no trauma exposure, 2) trauma-
exposed and endorsed no PTSD symptoms on the screen (referred to as trauma/no 
symptoms), 3) trauma-exposed and endorsed 1–3 PTSD symptoms (referred to as trauma/1–
3 symptoms), and 4) trauma-exposed and endorsed 4 or more PTSD symptoms (referred to 
as trauma/4+ symptoms). Prior to their first trauma (if one was reported), women were 
categorized as having no trauma exposure. After their first trauma, women were classified as 
trauma/no symptoms. Following their worst trauma, women were classified as trauma/no 
symptoms, trauma/1–3 symptoms, or trauma/4+ symptoms based on the number of PTSD 
symptoms reported with respect to the worst event. If women reported only one event, then 
the years of the first trauma and worst trauma were the same.
Cardiovascular Endpoint Assessment
At baseline, participants reported whether they ever experienced physician-diagnosed “MI 
or angina” or “stroke (CVA [cerebrovascular accident]) or TIA [transient ischemic attack]).” 
A positive response to any of these CVD endpoints at baseline resulted in exclusion from 
analyses. At each biennial follow-up, participants indicated whether they had a physician-
diagnosed “MI” or “stroke (CVA) or TIA” in the past 2 years. Consistent with prior 
research,4 we defined CVD events based on MI and stroke. TIA alone (n=39) was excluded. 
All CVD events were nonfatal. Physicians blind to participants’ trauma/PTSD status 
reviewed medical records to confirm reported CVD events after obtaining participants’ 
permission. MI was confirmed if it met World Health Organization criteria based on 
symptoms plus diagnostic ECG changes or elevated cardiac-specific enzyme 
concentrations.26 Stroke was confirmed based on National Survey of Stroke criteria as a 
neurological deficit with sudden or rapid onset that persisted for >24 hours or until death.27 
Cases confirmed by record review were considered “definite cases.” CVD events were 
classified as “probable cases” if a participant or relative acknowledged the reported 
diagnosis as correct but access to medical records was denied or unable to be attained. 
Trauma exposure and PTSD symptoms were not associated with differential rates of record 
refusal (χ2(df=3)=1.57, P=.67). In this study, we considered probable or definite CVD 
events based on the 1991–2009 questionnaires (n=548).
Covariates
Family history and childhood factors were included as potential confounders, specifically 
race/ethnicity (African American, Latina, Asian, Caucasian, other), maximum parental 
education at the participant’s birth (high school or less, some college, 4+ years of college), 
maternal and paternal history of MI or stroke, and somatotype at age five based on a 
somatogram scale (to estimate childhood adiposity).
Adult health behaviors and medical risk factors were examined as possible mediators of the 
PTSD-CVD association. These time-varying covariates were assessed at baseline via self-
report and updated biennially, unless otherwise noted (see Figure 1 for study timeline). 
Adult body mass index (BMI) in kg/m2 was computed from self-reported height and weight 
and coded continuously.28 In addition, participants were classified as nonsmokers, former 
smokers, or current smokers of 1–14, 15–24, or 25+ cigarettes/day. Alcohol consumption 
Sumner et al. Page 4









was assessed in 1989, 1991, 1995, 1999, 2003, and 2007, and categorized as 0, 1–4, 5–9, 
10–19, or 20+ grams/day. Physical activity was measured in 1989, 1991, 1997, 2001, and 
2005, and categorized as less than 3, 3–8.9, 9–17.9, 18–26.9, or 27+ metabolic equivalent 
hours/week. Diet quality was assessed every 4 years beginning in 1991 and quantified based 
on the Alternative Healthy Eating Index, which has been linked to CVD risk.29 Alternative 
Healthy Eating Index scores were divided into quintiles; the highest quintile represented the 
healthiest diet. Time-varying indicators for presence or absence of physician-diagnosed 
hypertension and type 2 diabetes mellitus, along with use of hormone therapy (HT; never 
used/premenopausal, current user, former user), were included as covariates given evidence 
for associations with MI or stroke.30–32 We also examined use of antidepressant medication 
(ADM), which is often prescribed for PTSD33 and has been linked to increased CVD risk.34 
Lifetime ADM use was assessed in 1993, and regular past two-year ADM use was assessed 
in 1997, 2001, 2003, 2005, and 2007. We created a single time-varying ADM use variable. 
Women who endorsed lifetime ADM use in 1993 were coded as having used ADM from 
1989–1993, and use was updated as available.
Sensitivity Analyses
Childhood abuse and depression have been associated with increased CVD risk in this 
cohort,4, 35 and we examined potential confounding by childhood abuse and depression prior 
to PTSD onset. Childhood sexual abuse (CSA) before age 18 was measured in 2001 with 
four questions regarding unwanted sexual touching or forced or coerced sexual contact by an 
adult or older child.36 Responses were coded as no sexual abuse, sexual touch only, or 
forced sex.4 Childhood physical abuse was assessed in 2001 with the revised Conflict 
Tactics Scale,37 and classified as none, mild, moderate, or severe.4 Depressive symptoms 
were assessed in 1993 with the 5-item Short Form-36 Mental Health scale, a mental health 
status measure found to be valid in screening for depression.38
Exclusions
A flowchart of participant exclusions used to derive the analytic sample (N=49,978) is 
depicted in Figure 2. Women excluded from analyses were similar to those included in terms 
of childhood adiposity (highest somatotype at age five: 6.9% vs. 6.9%), age at baseline (34.1 
vs. 34.7 years), BMI at baseline (24.3 vs. 23.8), and cumulative incidence of CVD events 
from 1989–2009 (1.2% vs. 1.1%), although they reported somewhat lower rates of family 
history of CVD: maternal history of MI (9.6% vs. 11.0%), maternal history of stroke (6.1% 
vs. 8.8%), paternal history of MI (26.1% vs. 29.6%), paternal history of stroke (8.9% vs. 
13.1%).
Statistical Analysis
We investigated whether trauma exposure and PTSD symptoms were associated with CVD 
incidence by using Cox proportional hazards models to calculate hazard ratios (HRs) and 
95% confidence intervals (CIs). Participants contributed person-time from baseline in 1989 
until their last returned questionnaire, CVD onset, or the end of follow-up based on the 2009 
questionnaire. Trauma exposure and PTSD symptoms at baseline were updated over the 
study period based on participants’ reported age at the worst trauma. Models were 
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constructed such that, for each time period of prediction (e.g., CVD from the 1993 
questionnaire), proposed mediators were lagged by one period (e.g., data from the 1991 
questionnaire) and trauma/PTSD status was lagged such that it represented the year prior to 
the period for the mediators (e.g., trauma/PTSD status in 1990).
We tested a series of models that sequentially adjusted for potential confounders and 
mediators. Model 1 adjusted for age and included dummy variables representing trauma/no 
symptoms, trauma/1–3 symptoms, and trauma/4+ symptoms. Model 2 adjusted for family 
history and childhood factors considered potential confounders (race/ethnicity, parental 
education, maternal and paternal history of MI or stroke, age five somatotype). Model 3 
adjusted for adult health behaviors that might serve as mediators of the PTSD-CVD 
association (BMI, cigarette smoking, alcohol intake, physical activity, diet quality). Model 4 
adjusted for all factors included in Model 3 plus medical risk factors that have been directly 
or indirectly linked with trauma exposure or PTSD as well as CVD (hypertension, type 2 
diabetes mellitus, HT use, ADM use). We investigated the extent to which health behaviors 
and medical risk factors in Model 4 might account for increased CVD risk in women with 
trauma exposure and PTSD symptoms using the SAS mediate macro.39,40 This macro 
calculates point estimates (and 95% CIs) of the percent of exposure effect explained by one 
or more intermediate variables, and is estimated on the coefficient scale.
To test potential confounding by childhood abuse, we re-estimated Model 2 adjusting for 
childhood abuse. We also investigated potential confounding by depression prior to PTSD 
onset by adjusting for depressive symptoms assessed in 1993 (the earliest depression 
measure in the NHS II). Depression can be triggered by PTSD41 and could mediate the 
PTSD-CVD association. We were most concerned with investigating whether depression 
prior to PTSD accounted for our results. To ensure depression occurred prior to PTSD, we 
began our prediction period after 1993 and excluded PTSD cases with onset in or prior to 
1993, resulting in a sample size of 40,356. We also examined potential effect modification 
by testing interactions between trauma/PTSD status with childhood abuse and early 
depression as these variables might potentiate the association between trauma/PTSD status 
and CVD. Additionally, we addressed the possible impact of recall bias in the retrospective 
reporting of trauma and PTSD given that most CVD events occurred prior to the trauma and 
PTSD assessment in 2008. We conducted an analysis that included only CVD events 
occurring after trauma and PTSD assessment (i.e., 163 CVD events reported on the 2009 
biennial questionnaire), adjusting for Model 2 covariates.
Results
Participant characteristics as a function of trauma exposure and PTSD symptoms at baseline 
are presented in Table 1. Approximately 30% of participants did not report any traumatic 
events at or prior to baseline. Just over 50% of women were classified as trauma/no 
symptoms at baseline, 9.5% of women were classified as trauma/1–3 symptoms, and 9.5% 
of women were classified as trauma/4+ symptoms. Compared to no trauma exposure, trauma 
exposure and PTSD symptoms were associated with higher rates of cigarette smoking and 
family history of MI and stroke, in addition to a greater likelihood of reporting the highest 
somatotype at age five. Over follow-up, an additional 4,372 women reported trauma 
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exposure. In the final period for predicting CVD incidence, approximately 21% of women 
were classified as having no trauma exposure, 47% as trauma/no symptoms, and 16% each 
as trauma/1–3 symptoms and trauma/4+ symptoms, respectively.
There were 548 probable or definite CVD events (277 MI and 271 stroke events) between 
1989 and 2009. Compared to no trauma exposure, both trauma/no symptoms and trauma/4+ 
symptoms were associated with increased risk of CVD incidence after adjusting for 
demographic, family history, and childhood factors (Table 2, Model 2). Women with 4 or 
more PTSD symptoms had the highest risk of a CVD event, followed by trauma-exposed 
women endorsing no symptoms, although the HRs for these two groups were not 
significantly different, P=.42. Endorsing 1–3 PTSD symptoms was not significantly 
associated with risk of CVD incidence, and the HRs for the trauma/no symptoms and 
trauma/4+ symptoms groups were significantly greater than the HR for the trauma/1–3 
symptoms group, Ps<.01. The associations between trauma/no symptoms and trauma/4+ 
symptoms with CVD incidence remained statistically significant, albeit somewhat 
attenuated, after adjusting for adult health behaviors (Table 2, Model 3). Adjusting for 
health conditions and CVD-associated medication use further attenuated the associations, 
although trauma/no symptoms remained significantly associated with elevated CVD risk 
(Table 2, Model 4). Trauma/PTSD status was significantly associated with all proposed 
health behavior and medical risk factor mediators, Ps<.05. Based on the SAS mediate macro 
and assuming their actions were fully those of mediation (and not confounding), adult health 
behaviors and medical risk factors accounted for 14% (95% CI, 3–25%) of the association of 
trauma/no symptoms with CVD and 47% (95% CI, 23–70%) of the association of trauma/4+ 
symptoms with CVD. There were no significant exposure-mediator interactions (Ps>.05), 
and confounding of mediator-outcome associations was minimized by statistically 
controlling for relevant variables, including demographics, family history, and childhood 
adiposity. Moreover, the effect estimates of the mediators were highly similar in models 
with and without these potential confounders, suggesting that confounding was minimal.
Prior research in this population has demonstrated an association of childhood abuse with 
CVD incidence.4 In the current sample (which overlapped somewhat, but not completely, 
with the sample used in the previous study4), CSA was associated with increased CVD risk 
(HR=1.23 [95% CI, 1.00–1.50] for sexual touching only and HR=1.62 [95% CI, 1.27–2.07] 
for forced sex) over and above age, family history, and childhood factors. Childhood 
physical abuse was not significantly associated with CVD incidence, Ps>.14. To investigate 
whether current findings were confounded by CSA, we conducted a sensitivity analysis 
adjusting for CSA. Trauma/no symptoms and trauma/4+ symptoms were still associated 
with increased risk of CVD (adjusting for covariates in Model 2; HR=1.37 [95% CI, 1.08–
1.73] for trauma/no symptoms; HR=0.91 [95% CI, 0.65–1.27] for trauma/1–3 symptoms; 
HR=1.39 [95% CI, 1.03–1.87] for trauma/4+ symptoms). Moreover, there was no significant 
interaction between CSA and trauma/PTSD status for CVD incidence, P=.28.
We also considered whether depressive symptoms might confound our findings. When 
covarying depressive symptoms in 1993 along with the covariates in Model 2, trauma/no 
symptoms and trauma/4+ symptoms were associated with elevated CVD risk; the HRs were 
close in magnitude to those in the original analyses, although the trauma/4+ symptoms-CVD 
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association fell short of statistical significance (HR=1.48 [95% CI, 1.15–1.91] for trauma/no 
symptoms; HR=1.07 [95% CI, 0.75–1.51] for trauma/1–3 symptoms; HR=1.53 [95% CI, 
0.90–2.61] for trauma/4+ symptoms). There was no significant interaction between 
depression and trauma/PTSD status for risk of incident CVD, P=.997.
In the prospective analysis predicting incident CVD based on the 2009 questionnaire 
(adjusted for covariates in Model 2), trauma/no symptoms and trauma/4+ symptoms were 
associated with increased risk of CVD incidence (HR=1.27 [95% CI, 0.83–1.94] for 
trauma/no symptoms; HR=0.79 [95% CI, 0.44–1.42] for trauma/1–3 symptoms; HR=1.42 
[95% CI, 0.86–2.34] for trauma/4+ symptoms). These findings did not reach statistical 
significance, likely given limited statistical power in this short follow-up period.
We also examined associations of trauma exposure and PTSD symptoms separately with 
incidence of probable or definite MI (n=277) and stroke (n=271) over the entire study period 
(Table 3). Results for MI were similar to those for overall CVD, with trauma/no symptoms 
and trauma/4+ symptoms associated with increased risk of MI incidence compared to no 
trauma exposure. Only trauma/4+ symptoms was significantly related to stroke incidence.
Discussion
We examined whether trauma exposure and PTSD symptoms were associated with risk of 
early-onset CVD (MI and stroke) over 20 years in a large, population-based cohort of female 
nurses. We have three key findings. First, higher PTSD symptoms (i.e., endorsing four or 
more symptoms on the PTSD screen) were associated with increased risk of CVD incidence. 
Second, trauma exposure alone (endorsing no PTSD symptoms on the screen) was 
associated with elevated CVD risk. Third, adult health behaviors and medical risk factors 
accounted for an estimated 14% of the association of trauma/no symptoms with CVD and an 
estimated 47% of the association of trauma/4+ symptoms with CVD. Our findings suggest 
that elevated PTSD symptoms and trauma exposure may each be associated with poor 
cardiovascular health. To our knowledge, this is the first study in women to 1) predict CVD 
events confirmed by additional information or record review, 2) consider the effects of 
trauma exposure separately from PTSD, and 3) examine health behaviors and medical risk 
factors as potential mediators of the associations between trauma exposure, PTSD 
symptoms, and CVD incidence.
Overall, our results are consistent with the broader PTSD-CVD literature, including the only 
other study conducted in women.18 In the present study, CVD risk was highest for women 
endorsing 4 or more symptoms on the PTSD screen, a commonly-used cutoff for probable 
PTSD diagnosis.25 Effect sizes remained elevated and similar in magnitude in sensitivity 
analyses adjusting for CSA and depression before PTSD onset, suggesting that these results 
were not simply reflecting previously demonstrated effects of CSA or depression. Elevated 
PTSD symptoms were also associated with increased risk of MI and stroke incidence when 
we examined these outcomes separately. Trauma-exposed women endorsing 1–3 PTSD 
symptoms on the screen did not have significantly elevated risk of CVD compared to 
women with no trauma. This result was unexpected because some research has found 
subthreshold PTSD to be associated with physical health problems.42 The 95% CI for the 
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HR for the trauma/1–3 symptoms group was wide, however, and included values greater 
than 1. Further research that assesses all PTSD symptom criteria using a clinical interview is 
needed to better understand associations of full and partial PTSD diagnoses with CVD.
Unlike most studies of PTSD and CVD, we examined associations of both trauma exposure 
and PTSD symptoms with CVD risk in a single investigation. Preliminary evidence in the 
literature suggests that trauma exposure is associated with physical health independent of 
psychopathology.43 Our finding that trauma exposure in women endorsing no PTSD 
symptoms was related to increased CVD risk is consistent with the notion that trauma 
exposure per se has negative health consequences, although additional risk factors are also 
likely at play. Furthermore, some researchers have suggested that trauma-exposed 
individuals who do not endorse any PTSD symptoms may engage in coping strategies (e.g., 
emotional suppression) that may generate physical distress and lead to negative physical 
health consequences,44 and our findings are congruent with this account. Although the NHS 
II data do not permit a detailed examination of this hypothesis, this would be of interest for 
further study. Overall, these results suggest that the effects of trauma on physical health may 
impact more than just those who develop PTSD symptoms. Nevertheless, more research is 
needed, particularly studies that assess multiple manifestations of posttraumatic 
psychopathology in order to account for alternative psychopathological responses to trauma 
that are not captured by PTSD.
Adult health behaviors and medical risk factors (including ADM use) accounted for an 
estimated 14% and 47% of the associations of trauma/no symptoms and trauma/4+ 
symptoms with CVD, respectively. Comprehensive investigations of the mechanisms 
linking PTSD to CVD are lacking,45 but previously we found that health behaviors and 
medical risk factors accounted for 60–80% of associations between childhood abuse and 
CVD incidence.4 Our findings suggest that health behavioral correlates explained some, but 
not all, of the trauma/no symptoms-CVD and trauma/4+ symptoms-CVD relations. 
Although measurement error could have attenuated these associations, additional 
mechanisms of risk are of interest for future study. Trauma exposure and PTSD are 
associated with dysregulation of the autonomic nervous system, hypothalamic-pituitary-
adrenal axis, and inflammatory response, and subsequent changes in catecholamines, 
cortisol, and inflammatory cytokines may increase CVD risk.45 Research measuring changes 
in CVD-related biomarkers from before to after trauma exposure and PTSD onset will help 
elucidate biological mechanisms. Furthermore, although we accounted for several health 
behaviors, data were unavailable on additional behavioral correlates of PTSD that may 
contribute to CVD. For example, insomnia and poor sleep quality (e.g., due to nightmares) 
are common in PTSD, and sleep problems (e.g., daytime sleepiness) have been associated 
with CVD risk.46
This study has several limitations. We used retrospective assessment of trauma and PTSD 
symptoms, and the precision of reports—particularly regarding dating of traumatic 
experiences—may have been reduced. Furthermore, trauma history and PTSD symptoms 
were measured in 2008, after many CVD events occurred. Nevertheless, trauma exposure 
and PTSD symptoms were associated with elevated CVD risk when we analyzed CVD 
events occurring only after trauma/PTSD assessment. Another limitation is that PTSD 
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symptoms were assessed with a screen that did not measure all diagnostic criteria. Thus, our 
results are not generalizable to clinical diagnoses. Additionally, because we twice lagged the 
primary exposure of trauma/PTSD in models to avoid effect-cause artifacts, some results 
might be underestimates if some of the effects of trauma and PTSD appear within a few 
years after trauma/PTSD onset. Further research examining the effects of time since trauma 
and PTSD duration with respect to CVD risk is needed.
Survivor bias is another concern because women needed to remain in the NHS II until 2008 
to provide data on trauma and PTSD. Given that PTSD has been associated with increased 
mortality risk,5 our findings may underestimate the PTSD-CVD relation if those with (vs. 
without) PTSD were more likely to die prior to PTSD assessment. However, the death rate 
in the NHS II is low and unlikely to substantially influence estimates; 1.6% of the original 
sample (n=1,826) was deceased by the trauma and PTSD assessment in 2008. Nevertheless, 
results should be considered in light of this limitation. Additionally, the NHS II cohort is 
predominantly white and highly educated, which may limit the generalizability of findings. 
Furthermore, because women were aged 44–64 years at the end of follow-up, our results 
pertain to nonfatal early-onset CVD. Additional research on trauma, PTSD, and later onset 
CVD (including fatal events) is needed.
The current study also has several strengths that make it unlike previous investigations. It is 
based on a large-scale long-running cohort that is well-characterized with regard to CVD 
risk and risk-related factors. We also considered the effects of PTSD in community-dwelling 
women exposed to a range of traumas. Additionally, we 1) evaluated trauma and PTSD in 
relation to validated CVD events as confirmed by additional information or record review; 
2) contrasted a no-trauma group with a trauma-exposed group endorsing no PTSD 
symptoms; and 3) incorporated longitudinal, repeated-measures data to estimate the impact 
of potential mediators. Thus, we believe that our findings have potential implications for 
treatment and prevention. Currently, neither the American Heart Association nor the 
American Stroke Association recognizes trauma or PTSD as risk factors for CVD,47 and 
there is no systematic approach for addressing CVD risk factors in trauma-exposed 
individuals with or without PTSD. Our findings, together with those in the literature, suggest 
that PTSD may be a modifiable risk factor for CVD. Additional research on the mechanisms 
underlying the relations between trauma, PTSD, and CVD will help to elucidate 
understanding of these associations. If research continues to demonstrate associations 
between trauma exposure, PTSD, and CVD incidence (particularly evidence for causal 
links), then assessing and monitoring cardiovascular function in trauma-exposed individuals 
and those with PTSD may have a positive public health impact and help to detect pre-
clinical markers of cardiovascular dysfunction. Furthermore, it will be important to examine 
whether successful PTSD treatment has a positive impact on cardiovascular health. In sum, 
broadly recognizing that trauma and PTSD, which are public health concerns in their own 
right, have more far-reaching effects on physical health than previously thought may begin 
to inform public health interventions aimed at reducing risk of CVD, the leading cause of 
morbidity and mortality.
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Timeline of variables collected at biennial assessments. CVD=cardiovascular disease. 
BMI=body mass index. T2D=type 2 diabetes mellitus. HTN=hypertension. HT=hormone 
therapy. ADM=antidepressant medication. Response rates for the analytic sample are listed 
for each time point. Trauma/PTSD status was assigned for each year of the study and 
updated based on reported age of worst trauma (assessed with a supplemental questionnaire 
in 2008).
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Flowchart of exclusions for deriving the final analytic sample.
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Table 1




No PTSD symptoms 
(n=25471) 1–3 symptoms (n=4751) 4+ symptoms (n=4751)
Age in 1989 34 years 35 years 35 years 35 years
Parents’ education at birth, ≥ college 23.7% (3555) 22.4% (5702) 22.9% (1089) 23.3% (1105)
Maternal history of MI* 9.4% (1413) 11.4% (2901) 11.8% (562) 13.4% (635)
Paternal history of MI 27.9% (4179) 30.1% (7662) 30.4% (1443) 31.3% (1489)
Maternal history of stroke 7.5% (1118) 9.4% (2397) 8.3% (395) 10.7% (510)
Paternal history of stroke 11.8% (1766) 13.5% (3444) 13.1% (622) 14.8% (701)
Highest somatotype, age 5 6.2% (928) 7.0% (1795) 6.7% (319) 8.0% (379)
Race
 African American 0.7% (111) 1.0% (265) 1.1% (51) 0.8% (37)
 Asian 1.6% (234) 1.2% (299) 0.9% (43) 0.8% (38)
 Caucasian 93.5% (14030) 93.8% (23894) 94.2% (4474) 94.6% (4496)
 Latina 0.9% (139) 1.4% (347) 1.5% (70) 1.3% (62)
 Other 3.3% (491) 2.6% (666) 2.4% (113) 2.5% (118)
Body mass index (kg/m2) 23.5 23.9 24.0 24.2
Cigarette Smoking
 Never 72.3% (10851) 65.8% (16749) 62.1% (2949) 58.7% (2788)
 Former smoker 18.1% (2718) 22.4% (5708) 25.0% (1187) 27.3% (1295)
 Current, 1–14 cigs/day 4.1% (612) 4.6% (1176) 5.0% (236) 5.1% (244)
 Current, 15–24 cigs/day 3.6% (542) 4.7% (1206) 5.0% (239) 5.9% (278)
 Current, 25+ cigs/day 1.6% (236) 2.2% (552) 2.5% (121) 2.7% (126)
 Missing 0.3% (46) 0.3% (80) 0.4% (19) 0.4% (20)
Alcohol Intake
 0 grams/day 35.9% (5392) 36.3% (9248) 36.2% (1722) 39.2% (1860)
 1–<5 grams/day 43.1% (6470) 42.7% (10875) 41.5% (1972) 40.1% (1906)
 5–<10 grams/day 11.2% (1675) 11.1% (2815) 11.2% (530) 10.2% (483)
 10–<20 grams/day 7.7% (1156) 7.5% (1921) 8.6% (409) 7.9% (377)
 20+ grams/day 1.3% (198) 1.6% (413) 1.9% (91) 1.8% (87)
 Missing 0.8% (114) 0.8% (199) 0.6% (27) 0.8% (38)
Physical Activity
 <3 MET hrs/wk† 14.6% (2194) 13.9% (3543) 15.2% (722) 14.4% (683)
 3–8.9 MET hrs/wk 23.3% (3498) 23.1% (5882) 23.5% (1115) 22.4% (1065)
 9–17.9 MET hrs/wk 21.0% (3156) 21.5% (5487) 21.3% (1011) 20.5% (976)
 18–26.9 MET hrs/wk 13.3% (1993) 13.3% (3391) 14.0% (665) 14.3% (677)
 27+ MET hrs/wk 27.8% (4164) 28.1% (7168) 26.1% (1238) 28.4% (1350)
Alternative Health Eating Index
 1st quintile (worst diet) 20.4% (3063) 18.0% (4593) 16.8% (799) 16.3% (774)
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No trauma (n=15005)
Trauma-exposed (n=34973)
No PTSD symptoms 
(n=25471) 1–3 symptoms (n=4751) 4+ symptoms (n=4751)
 2nd quintile 19.0% (2845) 18.4% (4692) 18.8% (891) 17.0% (806)
 3rd quintile 26.0% (3906) 25.9% (6586) 25.5% (1210) 25.4% (1205)
 4th quintile 17.5% (2619) 18.9% (4817) 18.0% (855) 18.9% (896)
 5th quintile (best diet) 16.7% (2510) 18.3% (4670) 20.6% (977) 22.0% (1047)




MET hrs/wk=metabolic equivalent hours per week.
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Table 3
Adjusted* hazard ratios (95% confidence intervals) for the association of trauma exposure and PTSD 
symptoms with risk of incident MI and stroke, 1989 to 2009
MI (n=277) Stroke (n=271)
No trauma exposure 1.00 1.00
Trauma/No symptoms 1.96 (1.38–2.78) 1.09 (0.80–1.50)
Trauma/1–3 symptoms 1.11 (0.68–1.81) 0.93 (0.59–1.44)
Trauma/4+ symptoms 1.58 (1.02–2.46) 1.64 (1.12–2.39)
*Adjusted for age, race/ethnicity, parental education, maternal and paternal history of MI or stroke, and age 5 somatotype.
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